ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report)’s share price was down 1.9% on Tuesday . The stock traded as low as $3.77 and last traded at $4.03. Approximately 3,329 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 99,556 shares. The stock had previously closed at $4.11.
ENDRA Life Sciences Price Performance
The firm has a market capitalization of $2.16 million, a price-to-earnings ratio of 0.00 and a beta of 0.43. The stock has a fifty day moving average of $4.85 and a two-hundred day moving average of $6.32.
About ENDRA Life Sciences
ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
Featured Stories
- Five stocks we like better than ENDRA Life Sciences
- Investing in Construction Stocks
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Energy and Oil Stocks Explained
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 5 Top Rated Dividend Stocks to Consider
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
